These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11034297)

  • 1. Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant antigens of M. tuberculosis.
    Dhar N; Rao V; Tyagi AK
    FEMS Microbiol Lett; 2000 Sep; 190(2):309-16. PubMed ID: 11034297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in bacille Calmette-Guérin.
    Rao V; Dhar N; Tyagi AK
    Scand J Immunol; 2003 Oct; 58(4):449-61. PubMed ID: 14507310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
    Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
    Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines.
    DasGupta SK; Jain S; Kaushal D; Tyagi AK
    Biochem Biophys Res Commun; 1998 May; 246(3):797-804. PubMed ID: 9618292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-plasmid system for stable, selective-pressure-independent expression of multiple extracellular proteins in mycobacteria.
    Harth G; Masleša-Galić S; Horwitz MA
    Microbiology (Reading); 2004 Jul; 150(Pt 7):2143-2151. PubMed ID: 15256557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering Mycobacteria for the Production of Self-Assembling Biopolyesters Displaying Mycobacterial Antigens for Use as a Tuberculosis Vaccine.
    Lee JW; Parlane NA; Rehm BHA; Buddle BM; Heiser A
    Appl Environ Microbiol; 2017 Mar; 83(5):. PubMed ID: 28087528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The construction and expression of Rv3872 as a member of virulent protein secret system from Mycobacterium tuberculosis in Bacillus Calmette-Guerin].
    Shi XX; Bao L; Qiu YQ; Guo S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jun; 26(6):539-42. PubMed ID: 20487645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel differential expression system for gene modulation in Mycobacteria.
    Fan XY; Ma H; Guo J; Li ZM; Cheng ZH; Guo SQ; Zhao GP
    Plasmid; 2009 Jan; 61(1):39-46. PubMed ID: 18835406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
    Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
    Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genes for immunodominant protein antigens are highly homologous in Mycobacterium tuberculosis, Mycobacterium africanum, and the vaccine strain Mycobacterium bovis BCG.
    Lu MC; Lien MH; Becker RE; Heine HC; Buggs AM; Lipovsek D; Gupta R; Robbins PW; Grosskinsky CM; Hubbard SC
    Infect Immun; 1987 Oct; 55(10):2378-82. PubMed ID: 2820881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis bacillus Calmette-Guérin, and Mycobacterium tuberculosis H37Rv by allelic exchange.
    Pavelka MS; Jacobs WR
    J Bacteriol; 1999 Aug; 181(16):4780-9. PubMed ID: 10438745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Recombinant Mycobacterium bovis BCG Expression Vectors: Improving Genetic Control over Mycobacterial Promoters.
    Kanno AI; Goulart C; Rofatto HK; Oliveira SC; Leite LCC; McFadden J
    Appl Environ Microbiol; 2016 Apr; 82(8):2240-2246. PubMed ID: 26850295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation of BCG vaccine: a double-edged sword.
    Singh VK; Srivastava R; Srivastava BS
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):535-43. PubMed ID: 26810060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis.
    Dhar N; Rao V; Tyagi AK
    Med Microbiol Immunol; 2004 Feb; 193(1):19-25. PubMed ID: 12905016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.
    Hart BE; Hale LP; Lee S
    PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004046. PubMed ID: 26393347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.